Truqap 160 mg (Capivasertib TABLET) 160 MG

Truqap 160 mg is a tablet containing capivasertib, used for targeted therapy in cancer treatment. This medication is designed to inhibit specific proteins involved in cell growth.

Strength

160 MG

Manufacturer / TM Owner

ASTRAZENECA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Truqap 160 mg tablets are generally used in the treatment of certain types of cancer. Capivasertib, the active ingredient, is a kinase inhibitor that targets proteins involved in cell proliferation. This medication is often considered for patients who have specific genetic markers that make them suitable candidates for this type of therapy.

Side Effects

Common effects of Truqap 160 mg may include fatigue, nausea, and diarrhea. Some individuals might experience changes in appetite or skin reactions. It's important to monitor any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Truqap 160 mg should be handled with care, following the guidance of a healthcare professional. It is essential to store the medication properly and adhere to the prescribed regimen. Patients should be aware of potential side effects and report any severe or persistent issues to their doctor.

Avoid Interactions

Truqap 160 mg may interact with other medications, including those that affect liver enzymes. It's crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods might also influence the effectiveness of this medication.

Frequently Asked Questions

Truqap 160 mg is used in the treatment of certain types of cancer, targeting specific proteins involved in cell growth.

Truqap 160 mg tablets are taken orally, typically following a schedule determined by your healthcare provider.

Common side effects may include fatigue, nausea, diarrhea, and changes in appetite.

It is generally advised to avoid alcohol while taking Truqap 160 mg, as it may interact with the medication.

Truqap 160 mg tablets should be stored at room temperature, away from moisture and heat.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.